QuintilesIMS
`-INSTITUTE-
`
`May 2017
`
`Advancing Academic
`
`Research
`
`Bibliography of Published Papers and
`
`Presentations Using QuintileslMS Information
`
`41000iO
`
`1iOOOOOi010101
`
`Argentum Pharm. LLC v. Alcon Research, Ltd.
`Case IPR2017-01053
`
`ALCON 2059
`
`

`

`
`
`Introduction
`
`
`
`QuintilesIMS information is used extensively by researchers around the world to
`advance understanding of key healthcare issues. As a leading global information
`and technology services company, we collaborate with academics and others
`whose research would be significantly advanced through access to QuintilesIMS
`proprietary information. This activity generates a large number of peer-reviewed
`publications and conference presentations, covering a broad range of topics.
`
`The range of information accessed and used for research purposes is extensive. It
`includes summarized global and national prescription drug volume and sales
`information; provider-level prescription information; de-identified longitudinal patient
`data; provider profiles and organizational relationships; and commercial insurance
`medical and pharmacy claims information.
`
`This bibliography provides a summary of research published from January 2010
`through December 2016 that was undertaken by U.S.-based researchers and
`utilized IMS Health data assets. The bibliography is in reverse chronological order
`by publication date and organized into four themes: Understanding Disease and
`Treatment Patterns, Providing Content for Healthcare Costs, Assessing Policy
`Levers, and Advancing Real World Patient-Level Clinical Evidence. Collectively,
`this research represents a substantial advancement in understanding the real-world
`operation of our health system, and is invaluable to multiple stakeholders. This
`bibliography has been produced as a public service without industry or government
`funding.
`
`
`Murray Aitken
`Executive Director
`QuintilesIMS Institute
`
`QuintilesIMS, 100 IMS Drive, Parsippany, NJ 07054, USA
`info@quintilesimsinstitute.org http://www.quintilesimsinstitute.org
`
`©2017 QuintilesIMS and its affiliates. All reproduction rights, quotations, broadcasting, publications reserved.
`No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
`mechanical, including photocopy, recording, or any information storage and retrieval system, without express
`written consent of QuintilesIMS and the QuintilesIMS Institute.
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`2
`
`

`

`
`
`
`
`Contents
`
`
`
`
`UNDERSTANDING DISEASE AND TREATMENT PATTERNS ................................................. 4
`
`PROVIDING CONTEXT FOR HEALTHCARE COSTS ............................................................... 9
`
`ASSESSING POLICY LEVERS ................................................................................................ 16
`
`ADVANCING REAL WORLD PATIENT-LEVEL CLINICAL EVIDENCE .................................. 21
`
`
`
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`3
`
`

`

`
`
`
`
`Understanding Disease and Treatment Patterns
`
`Potential adverse effects of long term use
`of Proton Pump Inhibitors
`Marshall Journal of Medicine. 2016;2(3):68
`Doshi MD, Shreyans M, Khamar MS, Kazumi A,
`Sehgal DV, Shah MD
`
`Antibiotic prescriptions in the community
`by type of provider in the United States,
`2005-2010
`Journal of the American Pharmacists
`Association. 2016 Dec 31;56(6):621-6
`Suda KJ, Roberts RM, Hunkler RJ, Taylor TH
`
`Dosing patterns and medication
`adherence in bipolar disorder patients
`treated with lurasidone: a US
`retrospective claims database analysis
`Therapeutic Advances in Psychopharmacology.
`2016 Dec;6(6):355-68
`Sajatovic M, Ng-Mak D, Solem CT, Lin FJ,
`Rajagopalan K, Loebel A
`
`Persistent sexual dysfunction with
`finasteride 1 mg taken for hair loss
`Pharmacotherapy: The Journal of Human
`Pharmacology and Drug Therapy. 2016 Nov
`1;36(11):1180-4
`Guo M, Heran B, Flannigan R, Kezouh A,
`Etminan M
`
`The Impact of collagenase clostridium
`histolyticum introduction on dupuytren
`treatment patterns in the United States
`The Journal of Hand Surgery. 2016 Oct
`31;41(10):963-8
`Zhao JZ, Hadley S, Floyd E, Earp BE, Blazar PE
`
`
`National and Northern New England
`opioid prescribing patterns, 2013–2014
`Pain Medicine. 2016 Oct 28:pnw231
`Toth AR, Possidente CJ, Sawyer LM, DiParlo MA,
`Fanciullo GJ
`
`Estimated incidence of pertussis in people
`aged< 50 years in the United States
`Human vaccines & immunotherapeutics. 2016
`Oct 2;12(10):2536-45
`Chen CC, Balderston McGuiness C, Krishnarajah
`G, Blanchette CM, Wang Y, Sun K, Buck PO
`
`Management of head louse infestations in
`the United States—a literature review
`Pediatric Dermatology. 2016 Sep 1;33(5):466-72
`Koch E, Clark JM, Cohen B, Meinking TL, Ryan
`WG, Stevenson A, Yetman R, Yoon KS
`
`Incidence and prevalence of acromegaly in
`the United States: a claims-based analysis
`Endocrine Practice. 2016 Aug 19;22(11):1327-35
`Broder MS, Chang E, Cherepanov D, Neary MP,
`Ludlam WH
`
`The HIV therapy market
`Nature Reviews Drug Discovery. 2016 Jul
`1;15(7):451-2
`Gubernick SI, Félix N, Lee D, Xu JJ, Hamad B
`
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`4
`
`

`

`
`
`
`
`IUD services among primary care
`practices in New York City
`Contraception (2015)
`Jacobson L, Garbers S, Helmy H, Roobol H,
`Kohn J, Kavanaugh M
`
`Epidemiology and treatment of new-onset
`and established rheumatoid arthritis in an
`insured US population
`Arthritis Care Res (Hoboken). 2015
`Dec;67(12):1646-55
`Crane MM, Juneja M, Allen J, Kurrasch RH,
`Chu ME, Quattrocchi E, Manson SC, Chang DJ
`
`National trends in ambulatory oral
`anticoagulant use
`Am J Med. 2015 Dec;128(12):1300-1305
`Barnes GD, Lucas E, Alexander GC,
`Goldberger ZD
`
`
`One-year treatment persistence with local
`estrogen therapy in postmenopausal
`women diagnosed as having vaginal
`atrophy
`Menopause. 2015 Nov;22(11):1197-203
`Portman D, Shulman L, Yeaw J, Zeng S,
`Uzoigwe C, Maamari R, Iyer NN
`
`Lipid-lowering treatment patterns among
`patients with type 2 diabetes mellitus with
`high cardiovascular disease risk
`BMJ Open Diabetes Res Care. 2015 Sep 23;3(1)
`Quek RG, Fox KM, Wang L, Li L, Gandra SR,
`Wong ND
`
`
`
`
`
`
`Metformin prescription patterns among
`US adolescents aged 10-19 years: 2009-
`2013
`J Clin Pharm Ther. 2016 Apr;41(2):229-36
`Wang T, McNeill AM, Chen Y, Senderak M,
`Shankar RR
`
`Prescriptions, nonmedical use, and
`emergency department visits involving
`prescription stimulants
`J Clin Psychiatry. 2016 Mar;77(3):e297-304
`Chen LY, Crum RM, Strain EC, Alexander GC,
`Kaufmann C, Mojtabai R
`
`Patient, physician and organizational
`influences on variation in antipsychotic
`prescribing behavior
`J Ment Health Policy Econ. 2016 Mar;19(1):45-59
`Tang Y, Chang CC, Lave JR, Gellad WF,
`Huskamp HA, Donohue JM
`
`Tablet/capsule size variation among the
`most commonly prescribed medications
`for children in the USA: retrospective
`review and firsthand pharmacy audit
`Paediatr Drugs. 2016 Feb;18(1):65-73
`Jacobsen L, Riley K, Lee B, Bradford K, Jhaveri R
`
` A
`
` US claims-based analysis of real-world
`lipid-lowering treatment patterns in
`patients with high cardiovascular disease
`risk or a previous coronary event
`Am J Cardiol. 2016 Feb 15;117(4):495-500
`Quek RG, Fox KM, Wang L, Li L,
`Gandra SR, Wong ND
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`5
`
`

`

`
`
`
`
`Association between outpatient antibiotic
`prescribing practices and community-
`associated clostridium difficile infection
`Open Forum Infect Dis. 2015 Aug 11;2(3)
`Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W,
`Beldavs ZG, Dumyati G, Farley MM, Holzbauer S,
`Meek J, Phipps E, Wilson L, Winston LG,
`McDonald LC, Lessa FC
`
`Prevalence of bone metastases and bone-
`targeting agent use among solid tumor
`patients in the United States
`Clin Epidemiol. 2015 Jul 17;7:335-45
`Hernandez RK, Adhia A, Wade SW, O'Connor E,
`Arellano J, Francis K, Alvrtsyan H, Million RP,
`Liede A
`
`Benzodiazepine use in the United States
`JAMA Psychiatry. 2015 Feb 1;
`72(2):136-42
`Olfson M, King M, Schoenbaum M
`
`Impact of abuse-deterrent OxyContin on
`prescription opioid utilization
`Pharmacoepidemiol Drug Saf 2015;24(2):
`197-204
`Hwang CS, Chang H-Y, Alexander GC
`
`Comparison of the risks of shopping
`behavior and opioid abuse between
`tapentadol and oxycodone and association
`of shopping behavior and opioid abuse
`Clin J Pain. 2014 Dec;30(12): 1051-6
`Cepeda MS, Fife D, Kihm MA,
`Mastrogiovanni G, Yuan Y
`
`
`
`
`
`Use of a claims database to characterize
`and estimate the incidence rate for
`Castleman disease
`Leuk Lymphoma. 2014 Sep 29:1-9
`Munshi N, Mehra M, van de Velde H, Desai A,
`Potluri R, Vermeulen J
`
`Impact of the ENHANCE trial on the use of
`ezetimibe in the United States and Canada
`American Heart Journal 2014;167(5):683-689
`Lu L, Krumholz HM, Tu JV, Ross JS, Ko DT,
`Jackevicius CA
`
`Trends in antibiotic resistance in
`coagulase-negative staphylococci in the
`United States, 1999 to 2012
`Antimicrob. Agents Chemother.
`2014;58(3):1404-1409
`May L, Klein EY, Rothman RE,
`Laxminarayan R
`
`Global antibiotic consumption 2000 to
`2010: an analysis of national
`pharmaceutical sales data
`Lancet Infect Dis 2014;14(8):742-750
`Van Boeckel TP, Gandra S, Ashok A, et al
`
`Reductions in reported deaths following
`the introduction of extended-release
`oxycodone (OxyContin) with an abuse-
`deterrent formulation
`Pharmacoepidemiol Drug Saf 2014;23(12):
`1238-1246
`Sessler NE, Downing JM, Kale H, Chilcoat HD,
`Baumgartner TF, Coplan PM
`
`Dipeptidyl peptidase-4 inhibitors and
`sulfonylureas for type 2 diabetes: friend or
`foe?
`J Diabetes Invest 2014;5(5):475-477
`Yabe D, Seino Y
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`6
`
`

`

`
`
`
`
`Use of prescription antiobesity drugs in
`the United States
`Pharmacotherapy. 2013 Dec;33(12):1299-307.
`Epub 2013 Sep 9
`Hampp C, Kang EM, Borders-Hemphill V
`
`Medication possession ratio: implications
`of using fixed and variable observation
`periods in assessing adherence with
`disease-modifying drugs in patients with
`multiple sclerosis
`Patient Prefer Adherence. 2013 Jun 12;7:
`509-16
`Kozma CM, Dickson M, Phillips AL,
`Meletiche DM
`
`Outpatient antibiotic prescribing, 2010
`New England Journal of Medicine
`2013;368(15):1461-1462
`Hicks LA, Taylor TH, Hunkler RJ
`
`Psychopharmacological prescriptions for
`people with autism spectrum disorder
`(ASD): a multinational study
`Psychopharmacology 2013;231(6):999-1009
`Hsia Y, Wong AYS, Murphy DGM, Simonoff E,
`Buitelaar JK, Wong ICK
`
`Trends in osteoporosis treatment with
`oral and intravenous bisphosphonates in
`the United States, 2002–2012
`Bone 2013;57(2):423-428
`Wysowski DK, Greene P
`
`The geography of antidepressant,
`antipsychotic, and stimulant utilization in
`the United States
`Health & Place. 2013; 20: 32-8
`King M, Essick C
`
`Should benzodiazepines be replaced by
`antidepressants in the treatment of
`anxiety disorders? Fact or fiction?
`Psychother Psychosom 2013;82:351–352
`Rickels K
`
`Technology diffusion in the antipsychotic
`market: a comparison of France and the
`USA between 1998 and 2008
`Psychiatr Serv 2013;64(7):680-687
`Gallini A, Huskamp HA, Donohue JM
`
`Medication use patterns and predictors of
`nonpersistence and nonadherence with
`oral 5-aminosalicylic acid therapy in
`patients with ulcerative colitis
`J Manag Care Pharm. 2012 Nov-Dec;18(9):
`701-12
`Yen L, Wu J, Hodgkins PL, Cohen RD,
`Nichol MB
`
`Association between unemployment rates
`and prescription drug utilization in the
`United States, 2007–2010
`BMC Health Services Research 2012;12(1):435
`Kozman D, Graziul C, Gibbons R, Alexander GC
`
`Incidence and predictors of venous
`thromboembolism (VTE) among
`ambulatory patients with lung cancer
`Lung Cancer 2012;78(3):253-258
`Connolly GC, Dalal M, Lin J,
`Khorana AA
`
`Methotrexate: underused and ignored?
`Digestive Diseases and Sciences. 2012; 30(3):
`112-8
`Herfarth HH, Long MD, Isaacs KL
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`7
`
`

`

`
`
`
`
`Lack of improvement in outpatient
`management of congestive heart failure in
`the United States
`Arch Intern Med 2010;170(15):1399-1400
`Banerjee D, Stafford RS
`
`Drug therapies for Parkinson’s disease: a
`database analysis of patient compliance
`and persistence
`The American Journal of Geriatric
`Pharmacotherapy 2010;8(4):374-383
`Tarrants ML, Denarié MF, Castelli-Haley J,
`Millard J, Zhang D
`
`
`
`
`
`
`
`
`Patterns of therapy switching,
`augmentation, and discontinuation after
`initiation of treatment with select
`medications in patients with osteoarthritis
`Clin Ther. 2011 Dec;33(12):1914-31. Epub 2011
`Nov 14 Gore M, Sadosky A, Leslie D, Tai KS,
`Seleznick M
`
`Persistence with non-selective NSAIDs
`and celecoxib among patients with
`gastroesophageal reflux disease and
`osteoarthritis or rheumatoid arthritis
`Curr Med Res Opin. 2011 Feb;27(2):295-302.
`Epub 2010 Dec 9
`Cryer B, Luo X, Assaf AR, Sands G,
`Mardekian J
`
`New drugs and new molecular entities in
`dermatology
`Arch Dermatol 2011;147(5):568-572
`Eaglstein WH, Corcoran G
`
`Prescription opioid analgesics rapidly
`change the human brain
`Pain 2011;152(8):1803-1810
`Younger JW, Chu LF, D’Arcy N, Trott K,
`Jastrzab LE, Mackey SC
`
`Estimating effect of antiviral drug use
`during pandemic (H1N1) 2009 outbreak,
`United States
`Emerging Infectious Diseases 2011;17(9):
`1591-1598 Atkins C
`
`Antimicrobial prescription
`data reveal wide geographic
`variability in antimicrobial use in the
`United States, 2009
`Infectious Diseases Society of America. Oct 2010
`Hicks LA, Suda KJ, Roberts RM, Hunkler R,
`Taylor TH Jr., Danziger LH
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`8
`
`

`

`
`
`
`
`
`
`Providing Context for Healthcare Costs
`
`Increasing economic burden of tyrosine
`kinase inhibitor treatment failure by line
`of therapy in chronic myeloid leukemia
`Curr Med Res Opin. 2016;32(2):289-99
`McGarry LJ, Chen YJ, Divino V, Pokras S, Taylor
`CR, Munakata J, Nieset CC, Huang H, Jabbour E,
`Malone DC
`
`Clinical and cost outcomes from different
`hyaluronic acid treatments in patients
`with knee osteoarthritis: evidence from a
`US health plan claims database
`Drugs in Context. 2016;5
`Dasa V, DeKoven M, Sun K, Scott A, Lim S
`
`Variation in rural health information
`technology adoption and use
`Health Affairs (2016): 10-1377
`Heisey-Grove DM
`
`Exacerbations, health services utilization,
`and costs in commercially-insured COPD
`patients treated with nebulized long-
`acting β2-agonists
`J Med Econ. 2016;19(1):11-20
`Chen YJ, Makin C, Bollu VK, Navaie M, Celli BR
`Chen YJ, Makin C, Bollu VK, Navaie M, Celli BR
`
`Quantifying differences in health care
`consumption for the management of
`multiple sclerosis within privately and
`publicly insured health care programs
`Journal of Managed Care & Specialty Pharmacy.
`2016 Dec;22(12):1385-91
`Livingston T, Fay M, Iyer R, Wells W, Pill MW
`
`
`Improving medication adherence and
`health care outcomes in a commercial
`population through a community
`pharmacy
`Population health management. 2016 Dec
`1;19(6):454-61
`Akinbosoye OE, Taitel MS, Grana J, Hill J, Wade
`RL
`
`Health care utilization and costs
`associated with nausea and vomiting in
`patients receiving oral immediate-release
`opioids for outpatient acute pain
`management
`Pain and Therapy. 2016 Dec 1;5(2):215-26
`Marrett E, Kwong WJ, Frech F, Qian C
`
`
`Orphan drug expenditures in The United
`States: A historical and prospective
`analysis, 2007–18
`Health Affairs. 2016 Sep 1;35(9):1588-94
`Divino V, DeKoven M, Kleinrock M, Wade RL,
`Kaura S
`
`
`National trends in prescription drug
`expenditures and projections for 2016
`American Journal of Health-System Pharmacy.
`2016 Jul 15;73(14):1058-75
`Schumock GT, Li EC, Suda KJ, Wiest MD,
`Stubbings J, Matusiak LM, Hunkler RJ,
`Vermeulen LC
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`9
`
`

`

`
`
`
`
`Regional variation in physician adoption
`of antipsychotics: Impact on US Medicare
`expenditures
`The journal of mental health policy and
`economics. 2016 Jun;19(2):69
`Donohue JM, Normand SL, Horvitz-Lennon M,
`Men A, Berndt ER, Huskamp HA
`
`Disease control, health resource use,
`healthcare costs, and predictors in gout
`patients in the United States, the United
`Kingdom, Germany, and France: A
`retrospective analysis
`Rheumatology and Therapy. 2016 Jun 1;3(1):53-
`75
`Morlock R, Chevalier P, Horne L, Nuevo J,
`Storgard C, Aiyer L, Hines DM, Ansolabehere X,
`Nyberg F
`
`Clinical and cost outcomes from different
`hyaluronic acid treatments in patients
`with knee osteoarthritis: evidence from a
`US health plan claims database
`Drugs in Context. 2016;5
`Dasa V, DeKoven M, Sun K, Scott A, Lim S
`
`Cancer drugs provide positive value in
`nine countries, but the United States lags
`in health gains per dollar spent
`Health Affairs. 2016 May 1;35(5):813-23
`Salas-Vega S, Mossialos E
`
`Economic burden of HIV antiretroviral
`therapy adverse events in the United
`States
`Health economics (2015)
`Dekoven M, Makin C, Slaff S, Marcus M,
`Maiese EM
`
`
`
`Determinants of US prescription drug
`utilization using county level data
`National Bureau of Economic Research, 2015
`Nianogo T, Okunade A, Fofana D, Chen W
`
`The effect of hospital/physician
`integration on hospital choice
`National Bureau of Economic Research, 2015
`Baker LC., Bundorf MK, Kessler DP
`
`National trends in prescription drug
`expenditures and projections for 2015
`Am J Health Syst Pharm 2015;72(9):717-736
`Schumock GT, Li EC, Suda KJ, et al
`
`Most uninsured adults could schedule
`primary care appointments before the
`ACA, but average price was $160
`Health Affairs 34, no. 5 (2015): 773-780
`Saloner B, Polsky D, Kenney GM, Hempstead K,
`Rhodes KV
`
`Market power, transactions costs, and the
`entry of accountable care organizations in
`health care
`Review of Industrial Organization 47, no. 2
`(2015): 167-193
`Frech III, HE, Whaley C, Handel BR, Bowers L,
`Simon CJ, Scheffler RM
`
`Economic burden of tyrosine kinase
`inhibitor treatment failure in chronic
`myeloid leukemia
`Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11)
`Knopf KB, Divino V, McGarry LJ, Chen YJ,
`Pokras S, Munakata J, Taylor C, Ng D, Nieset CC,
`Huang H
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`10
`
`

`

`
`
`
`
`Influenza antiviral expenditures and
`outpatient prescriptions in the United
`States, 2003-2012
`Pharmacotherapy. 2015 Nov; 35(11):991-7
`Suda KJ, Hunkler RJ, Matusiak LM,
`Schumock GT
`
`The budget impact of orphan drugs in ihe
`Us and Canada: a 2007-2013 Midas sales
`data analysis
`Value Health. 2015 Nov;18(7):A666
`Divino V, DeKoven M, Kim T, Kleinrock M,
`Wade RL, Kaura S
`
`Clinical and economic burden of
`breakthrough seizures
`Epilepsy Behav. 2015 Oct;51:40-7
`Divino V, Petrilla AA, Bollu V, Velez F,
`Ettinger A, Makin C
`
`Accuracy of annual prescription drug
`expenditure forecasts in AJHP
`Am J Health Syst Pharm. 2015 Oct 1;72(19):
`1642-8
`Hartke PL, Vermeulen LC, Hoffman JM, Shah
`ND, Doloresco F, Suda KJ, Li EC, Matusiak LM,
`Hunkler RJ, Schumock GT
`
`Healthcare costs among patients with
`excessive sleepiness associated with
`obstructive sleep apnea, shift work
`disorder, or narcolepsy
`Am Health Drug Benefits. 2014 Sep;7(6):
`334-40
`Carlton R, Lunacsek O, Regan T, Carroll CA
`
`
`
`
`Treatment patterns and costs for
`metastatic renal cell carcinoma patients
`with private insurance in the United States
`Clin Genitourin Cancer. 2014 Sep 28. pii: S1558-
`7673(14)00206-7
`Geynisman DM, Hu JC, Liu L, Tina Shih YC
`
`Hidden costs associated with venous
`thromboembolism: impact of lost
`productivity on employers and employees
`J Occup Environ Med. 2014 Sep;56(9):979-85
`Page RL 2nd, Ghushchyan V, Gifford B, Read RA,
`Raut M, Bookhart BK, Naim AB, Damaraju CV,
`Nair KV
`
`Comparison of health services use
`associated with ziprasidone and
`olanzapine among schizophrenia and
`bipolar disorder patients in the USA
`Clin Drug Investig. 2014 Jul;34(7):491-9
`Jiang Y, Ni W, McGinnis JJ
`
`Behind the scenes: sources of
`complementarity in R&D
`Journal of Economics & Management Strategy
`2014;23(1):125-148
`Ceccagnoli M, Higgins MJ, Palermo V
`
`National health spending in 2012: rate of
`health spending growth remained low for
`the fourth consecutive year
`Health Aff 2014;33(1):67-77
`Martin AB, Hartman M, Whittle L, Catlin A,
`NHEA Team
`
`National trends in prescription drug
`expenditures and projections for 2014
`Am J Health Syst Pharm 2014;71(6):482-499
`Schumock GT, Li EC, Suda KJ, et al
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`11
`
`

`

`
`
`
`
`Projecting future drug expenditures in
`U.S. nonfederal hospitals and clinics-2013
`Am J Health Syst Pharm 2013;70(6):525-539
`Hoffman JM, Li E, Doloresco F, et al
`
` A
`
` national evaluation of antibiotic
`expenditures by healthcare setting in the
`United States, 2009
`J. Antimicrob. Chemother. 2013;68(3):715-718
`Suda KJ, Hicks LA, Roberts RM, Hunkler RJ,
`Danziger LH
`
`The determinants of pricing in
`pharmaceuticals: Are US prices really so
`high?
`Health Econ 2013;22(11):1377-1397
`Cabrales A, Jiménez-Martín S
`
`Prevalence of off-label use and spending
`in 2010 among patent-protected
`chemotherapies in a population-based
`cohort of medical oncologists
`J Clin Oncol 2013;31(9):1134-1139
`Conti RM, Bernstein AC, Villaflor VM,
`Schilsky RL, Rosenthal MB, Bach PB
`
`Medical service encounters and payments
`associated with topical adjunctive therapy
`use of timolol for glaucoma
`Clin Drug Investig. 2012 Dec;32(12):835-42
`Schmier JK, Covert DW, Lau EC
`
`
`
`
`
`
`Costs of tumor necrosis factor blockers
`per treated patient using real-world drug
`data in a managed care population
`J Manag Care Pharm. 2013 Oct;19(8):621-30
`Schabert VF, Watson C, Joseph GJ, Iversen P,
`Burudpakdee C, Harrison DJ
`
`Differences in rates of hypoglycemia and
`health care costs in patients treated with
`insulin aspart in pens versus vials
`Curr Med Res Opin. 2013 Oct;29(10):1287-96.
`Epub 2013 Aug 7
`Asche CV, Luo W, Aagren M
`
`The economic burden of acute coronary
`syndromes for employees and their
`dependents: medical and productivity
`costs
`J Occup Environ Med. 2013 Jul;55(7):761-7
`Page RL 2nd, Ghushchyan V, Gifford B, Read RA,
`Raut M, Crivera C, Naim AB, Damaraju CV,
`Nair KV
`
`Annual all-cause healthcare costs among
`influenza patients with and without
`influenza-related complications: analysis
`of a United States managed care database
`Appl Health Econ Health Policy. 2013
`Apr;11(2):119-28
`Karve S, Misurski D, Herrera-Taracena G,
`Davis KL
`
`Perspectives for managed care
`organizations on the burden of multiple
`sclerosis and the cost-benefits of disease-
`modifying therapies
`J Manag Care Pharm. 2013 Jan-Feb;19
`(1SupplA):S41-53
`Owens GM, Olvey EL, Skrepnek GH, Pill MW
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`12
`
`

`

`
`
`
`
`Healthcare utilization and comorbidity
`burden among children and young adults
`in the United States with systemic lupus
`erythematosus or inflammatory bowel
`disease
`J Pediatr. 2012 Oct;161(4):662-670.e2. Epub
`2012 May 10
`Karve S, Candrilli S, Kappelman MD,
`Tolleson-Rinehart S, Tennis P, Andrews E
`
`Use and costs of prescription medications
`and alternative treatments in patients
`with osteoarthritis and chronic low back
`pain in community-based settings
`Pain Pract. 2012 Sep;12(7):550-60
`Epub 2012 Feb 5
`Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR
`
`Association between oral 5-ASA adherence
`and health care utilization and costs
`among patients with active ulcerative
`colitis
`BMC Gastroenterol. 2012 Sep 24;12:132
`Mitra D, Hodgkins P, Yen L, Davis KL,
`Cohen RD
`
`The burden of chronic low back pain:
`clinical comorbidities, treatment patterns,
`and health care costs in usual care settings
`Spine (Phila Pa 1976). 2012 May 15;37(11):
`E668-77
`Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D
`
`New bundled world: quality of care and
`readmission in diabetes patients
`J Diabetes Sci Technol. 2012 May 1;6(3):563-71
`Chen JY, Ma Q, Chen H, Yermilov I
`
`
`Comparative effectiveness, cost, and
`utilization of radical prostatectomy among
`young men within managed care
`insurance plans
`Value Health. 2012 Mar-Apr;15(2):367-75
`Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF,
`Davis JW, Thompson BP, Elting LS
`
`Impact of the 2008-2009 economic
`recession on screening colonoscopy
`utilization among the insured
`Clin Gastroenterol Hepatol. 2012 Mar;10(3):
`278-84
`Dorn SD, Wei D, Farley JF, Shah ND,
`Shaheen NJ, Sandler RS, Kappelman MD
`
`Cost of self-monitoring of blood glucose in
`the United States among patients on an
`insulin regimen for diabetes
`J Manag Care Pharm. 2012
`Jan-Feb;18(1):21-32
`Yeaw J, Lee WC, Aagren M, Christensen T
`
`The burden of chronic low back pain with
`and without a neuropathic component: a
`healthcare resource use and cost analysis
`J Med Econ. 2012;15(2):245-52. Epub 2011 Dec 5
`Mehra M, Hill K, Nicholl D, Schadrack J
`
`Annual costs of tumor necrosis factor
`inhibitors using real-world data in a
`commercially insured population in the
`United States
`J Med Econ. 2012;15(2):264-75
`Schabert VF, Watson C, Gandra SR, Goodman S,
`Fox KM, Harrison DJ
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`13
`
`

`

`
`
`
`
`Proton pump inhibitors: potential cost
`reductions by applying prescribing
`guidelines
`BMC Health Services Research 2012;12(1):408
`Cahir C, Fahey T, Tilson L, Teljeur C, Bennett K
`
`Growth in US health spending remained
`slow in 2010; health share of gross
`domestic product was unchanged from
`2009
`Health Aff 2012;31(1):208-219
`Martin AB, Lassman D, Washington B, Catlin A,
`NHEA Team
`
`Projecting future drug expenditures--2012
`Am J Health Syst Pharm 2012;69(5):405-421
`Hoffman JM, Li E, Doloresco F, et al
`
`Clinical comorbidities, treatment
`patterns, and healthcare costs among
`patients with fibromyalgia newly
`prescribed pregabalin or duloxetine in
`usual care
`J Med Econ. 2012;15(1):19-31
`Gore M, Tai KS, Chandran A, Zlateva G, Leslie D
`
`Impact of infliximab adherence on
`Crohn's disease-related healthcare
`utilization and inpatient costs
`Adv Ther. 2011 Aug;28(8):671-83.
`Epub 2011 Aug 3
`Carter CT, Waters HC, Smith DB
`
`Internal versus external R&D:
`complements or substitutes
`Journal of Economic Literature. Aug 2011
`Ceccagnoli M, Higgins MJ, Palermo V
`
`
`Cost of acute hospitalization and post-
`discharge follow-up care for
`meningococcal disease in the US
`Hum Vaccin. 2011 Jan 1;7(1):96-101. Epub 2011
`Jan 1
`Davis KL, Misurski D, Miller JM, Bell TJ,
`Bapat B
`
`Clinical comorbidities, treatment
`patterns, and direct medical costs of
`patients with osteoarthritis in usual care:
`a retrospective claims database analysis
`J Med Econ. 2011;14(4):497-507.
`Epub 2011 Jun 20
`Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR
`
`Commercial importation of prescription
`drugs in the United States: short-run
`implications
`J Health Polit Policy Law 2011;36(2):295-316
`Danzon PM, Johnson SJ, Long G,
`Furukawa MF
`
`Impact of new drugs and biologics on
`colorectal cancer treatment and costs
`American Journal of Managed Care.
`2011;17:e160-e168
`Karaca-Mandic P, McCullough JS, Siddiqui MA,
`Van Houten H, Shah ND
`
`Projecting future drug expenditures—2011
`Am J Health-Syst Pharm—Vol 68, 2011
`Doloresco F, Fominaya C, Schumock GT,
`Vermeulen LC, Matusiak L, Hunkler RJ,
`Shah ND, Hoffman JM
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`14
`
`

`

`
`
`
`
`Impact of a prior authorization for
`pregabalin on health plan drug
`expenditures
`Am J Manag Care. 2010 May;16(5 Suppl):S154-9
`Bazalo G, Weiss RC, Joshi AV
`
`The discrepancy in attention deficit
`hyperactivity disorder (ADHD)
`medications diffusion: 1994-2003--A
`global pharmaceutical data analysis
`Health Policy 2010;97(1):71-78
`Lang H-C, Scheffler RM, Hu T-W
`
`
`
`
`
`
`
`
`
`A cost-minimization analysis of
`dexmedetomidine compared with
`midazolam for long-term sedation in the
`intensive care unit
`Critical Care Medicine 2010;38(2):497-503
`Dasta JF, Kane-Gill SL, Pencina M, et al
`
`Trends in home phototherapy adoption in
`the US: monetary disincentives are only
`the tip of the iceberg
`J Dermatolog Treat 2010;22(1):27-30
`Yentzer BA, Feldman SR
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`15
`
`

`

`
`
`
`
`Assessing Policy Lever
`
`Effects of regulation and payment policies
`on nurse practitioners’ clinical practices
`Medical Care Research and Review (2016)
`Barnes, H, Maier CB, Sarik DA, Germack HD,
`Aiken LH, McHugh MD
`
`Fentanyl law enforcement submissions
`and increases in synthetic opioid–involved
`overdose deaths—27 states, 2013–2014
`MMWR. Morbidity and Mortality Weekly Report.
`2016;65
`Gladden RM
`
`Dosing of selective serotonin reuptake
`inhibitors among children and adults
`before and after the FDA black-box
`warning
`Psychiatric services. 2015 Nov 16;67(3):302-9
`Bushnell GA, Stürmer T, Swanson SA, White A,
`Azrael D, Pate V, Miller M
`
`Effect of US Food and Drug
`Administration–approved pediatric
`labeling on dispensing of extended-release
`oxycodone in the outpatient retail setting
`JAMA pediatrics. 2016 Nov 1;170(11):1103-4.
`Xu J, Gill R, Cruz M, Staffa J, Lurie P
`
`Branstetter L, Chatterjee C, Higgins MJ
`Regulation and welfare: evidence from
`paragraph IV generic entry in the
`pharmaceutical industry
`The RAND Journal of Economics. 2016 Nov
`1;47(4):857-90
`Branstetter L, Chatterjee C, Higgins MJ
`
`
`
`
`Updated trends in US brand-name and
`generic drug competition.
`Journal of medical economics. 2016 Sep
`1;19(9):836-44
`Grabowski H, Long G, Mortimer R, Boyo A
`
`Impact of prescription drug monitoring
`programs and pill mill laws on high-risk
`opioid prescribers: A comparative
`interrupted time series analysis
`Drug and alcohol dependence. 2016 Aug 1;165:1-
`8
`Chang HY, Lyapustina T, Rutkow L, Daubresse
`M, Richey M, Faul M, Stuart EA, Alexander GC
`
`
`ER/LA opioid analgesics REMS: overview
`of ongoing assessments of its progress and
`its impact on health outcomes
`Pain Medicine. 2016 Jul 2:pnw129
`Cepeda MS, Coplan PM, Kopper NW, Maziere JY,
`Wedin GP, Wallace LE
`
`
`Seeking balance between pain relief and
`safety: CDC issues new opioid-prescribing
`guidelines
`JAMA neurology. 2016 May 1;73(5):513-4
`Renthal W
`
`Effect of US drug enforcement
`administration’s rescheduling of
`hydrocodone combination analgesic
`products on opioid analgesic prescribing
`JAMA internal medicine. 2016 Mar 1;176(3):399-
`402
`Jones CM, Lurie PG, Throckmorton DC
`
`
`
`
` Advancing Academic Research. Bibliography of Published Papers and Presentations Using QuintilesIMS Data.
`
`16
`
`

`

`
`
`
`
`Effect of a “pill mill” law on opioid
`prescribing and utilization: The case of
`Texas
`Drug and alcohol dependence. 2016 Feb
`1;159:190-7
`Lyapustina T, Rutkow L, Chang HY,
`Daubresse M, Ramji AF, Faul M, Stuart EA,
`Alexander GC
`
`Nurse practitioner and physician assistant
`staffing in the patient-centered medical
`homes in New York State
`Nursing outlook 63, no. 5 (2015): 593-600
`Park J
`
`Solo practitioners remain important
`contributors to primary care
`The Journal of the American Board of Family
`Medicine 28, no. 1 (2015): 7-10
`Peikes DN, Dale SB
`
`Electronic medical record adoption in
`
`Oklahoma practices: rural‐urban
`
`differences and the role of broadband
`availability
`The Journal of Rural Health 31, no. 1 (2015): 47-
`57
`Whitacre BE, Williams RS
`
`Patient-centered medical homes and
`access to services for new primary care
`patients
`Medical care 53, no. 10 (2015): 857-862
`Aysola J, Rhode